from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1260/-

LFCtreatmentdescriptionclass of inhibitor

-1.169

Amikacinug/mL Amikacintranslation

0.297

Cap5-10ug/mL Capreomycintranslation

0.696

Rox10-50 ug/mL Roxithromycintranslation

0.540

SM2-5 ug/mL Streptomycintranslation

-1.420

Tet5-10 ug/mL Tetracyclinetranslation

0.483

Rif0.2-5ug/mL Rifampicintranscription

-0.335

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.400

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.302

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.220

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.842

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.096

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.911

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.232

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.690

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.140

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.177

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.455

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.187

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.159

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.214

KCN5-20 ug/mL Potassium cyaniderespiration

1.314

NaN30.2-2 mM Sodium aziderespiration

-0.507

Nigericin50 uM Nigericinrespiration

-0.801

TRC10-150 ug/mL Triclosanrespiration

-0.360

TRZ10-25 ug/mL Thioridazinerespiration

-0.850

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.851

menadione6-10 ug/mL Menadionerespiration

-0.751

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.634

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.609

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.194

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.673

NRP_1Non-replicating persistence stage 1dosRassociated

0.083

Amp0.2mg/mL AmpicillincellWall

-0.122

Cephalexin20-100 ug/mL CephalexincellWall

0.181

Cerulenin0.32-5 ug/mL CerulenincellWall

0.051

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.044

EMB10-20 ug/mL EthambutolcellWall

-0.811

Eta12-40 ug/mL EthionamidecellWall

-0.655

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.199

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.726

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-2.159

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.323

BZA0.12 mg/mL BenzamidearomaticAmides

1.006

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.858

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.453

H2O24 mM hydrogen peroxideDNAdamaging

0.789

Levo10 ug/mL LevofloxacinDNAdamaging

0.912

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.182

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.207

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.984

UVUV-irradiationDNAdamaging

-0.991

ARP41-4 ug/mL Antitubercular compound ARP4?

0.210

Antimycin12.5-50 ug/mL Antimycin A?

-0.910

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.013

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.365

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.139

PA8240.2-2 ug/mL PA-824?

-0.523

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.834

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.578

Verapamil50 uM Verapamil?

-1.030

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.062

methoxatin10-20 ug/mL Methoxatin?